References
- Sipe J, Benson M, Buxbaum J, et al. Amyloid fibril proteins and amyloidosis: chemical identification and clinical classification International Society of Amyloidosis 2016 Nomenclature Guidelines. Amyloid. 2016; 23:209–213.
- Wakhlu A, Krisnani N, Hissaria P, et al. Prevalence of secondary amyloidosis in Asian North Indian patients with rheumatoid arthritis. J Rheumatol. 2003;30:948–951.
- El Mansoury TM, Hazenberg BP, El Badawy SA, et al. Screening for amyloid in subcutaneous fat tissue of Egyptian patients with rheumatoid arthritis: clinical and laboratory characteristics. Ann Rheum Dis. 2002;61:42–47.
- Lachmann HJ, Goodman HJ, Gilbertson JA, et al. Natural history and outcome in systemic AA amyloidosis. N Engl J Med. 2007;356:2361–2371.
- Motoyama H, Fujimoto T, Yamashina A, et al. Primary nodular pulmonary amyloidosis (in Japanese). J Jpn Assoc Chest Surg. 2009;23:71–74.
- Jiang J, Browning R, Lechtzin N, et al. TBNA with and without EBUS: a comparative efficacy study for the diagnosis and staging of lung cancer. J Thorac Dis. 2014;6:416–420.
- Muhammad N, Murakami T, Inoshima Y, et al. Long-term kinetics of AA amyloidosis and effects of inflammatory restimulation after disappearance of amyloid depositions in mice. Clin Exp Immunol. 2015;181:133–141.
- Khoor A, Colby TV. Amyloidosis of the lung. Arch Pathol Lab Med. 2017;141:247–254.
- Milani P, Basset M, Russo F, et al. The lung in amyloidosis. Eur Respir Rev. 2017;26:170046.
- Calatayud J, Candelas G, Gómez A, et al. Nodular pulmonary amyloidosis in a patient rheumatoid arthritis. Clin Rheumatol. 2007;26:1797–1798.
- Herth F, Becker HD, Ernst A. Conventional vs endobronchial ultrasound-guided transbronchial needle aspiration: a randomized trial. Chest. 2004;125: 322–325.
- Vaidyanathan S, Patel CN, Scarsbrook AF, et al. FDG PET/CT in infection and inflammation-current and emerging clinical applications. Clin Radiol. 2015;70:787–800.
- Baqir M, Lowe V, Yi ES, et al. 18F-FDG PET scanning in pulmonary amyloidosis. J Nucl Med. 2014;55:565–568.
- Quan XQ, Yin TJ, Zhang CT, et al. (18) F-FDG PET/CT in patients with nodular pulmonary amyloidosis: case report and literature review. Case Rep Oncol. 2014;7:789–798.
- Umeda Y, Demura Y, Takeda N, et al. FDG-PET findings of nodular pulmonary amyloidosis with a long-term observation (in Japanese). Nihon Kokyuki Gakkai Zasshi. 2007;45:424–429.
- Nakamura T, Higashi S, Tomoda K, et al. Significance of SAA1,3 alle genotype in Japanese patients with amyloidosis secondary to rheumatoid arthritis. Rheumatology (Oxford). 2006;45:43–49.
- Kuroda T, Tanabe N, Kobayashi D, et al. Treatment with biologic agents improves the prognosis of patients with rheumatoid arthritis and amyloidosis. J Rheumatol. 2012;39:1348–1354.
- Obici L, Raimondi S, Lavatelli F, et al. Susceptibility to AA amyloidosis in rheumatic diseases: a critical overview. Arthritis Rheum. 2009;61:1435–1440.
- Lane T, Gillmore JD, Wechalekar AD, et al. Therapeutic blockade of interleukin-6 by tocilizumab in the management of AA amyloidosis and chronic inflammatory disorders: a case series and review of the literature. Clin Exp Rheumatol. 2015;33:S46–S53.